SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001661181-20-000023
Filing Date
2020-04-24
Accepted
2020-04-24 20:43:10
Documents
1
Period of Report
2020-04-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3409
  Complete submission text file 0001661181-20-000023.txt   4875
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Issuer) CIK: 0001661181 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O AVISTA CAPITAL PARTNERS 65 EAST 55TH STREET, 18TH FLOOR NEW YORK NY 10022
Business Address
Tamaroff Joshua Alexander (Reporting) CIK: 0001705548 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37906 | Film No.: 20816954